| Literature DB >> 31861107 |
Hai-Xia Liao1,2,3,4, Tai-Ming Shao4, Rong-Qing Mei1,2, Guo-Lei Huang1,2, Xue-Ming Zhou1,2, Cai-Juan Zheng1,2, Chang-Yun Wang3.
Abstract
Two new polyketides, 8-O-methylnodulisporin F (1) and nodulisporin H (2), two new naphthoquinones, 5-hydroxy-2-methoxy-6,7-dimethyl-1,4-naphthoquinone (3) and 5-hydroxy-2-methoxynaphtho[9-c]furan-1,4-dione (4), and a new naphthofuran 1,3,8-trimethoxynaphtho[9-c]furan (5), along with five known compounds 4-O-methyl eleutherol (6), 2-acetyl-7-methoxybenzofuran (7), (-)-orthosporin (8), diaporthin (9), and 6-hydroxymellein (10), were obtained from the EtOAc extract of the mangrove-derived fungus Daldinia eschscholtzii HJ004. The structures of the isolated compounds were elucidated by extensive NMR and MS analyses, while the absolute configurations of the stereogenic carbons were established based on experimental and calculated electronic circular dichroism spectra. Compounds 4 and 7 displayed a potent inhibitory activity against α-glucosidase with the IC50 values of 5.7 and 1.1 μg/mL, respectively. Compounds 1 and 2 showed a moderate antibacterial activity against Staphylococcus aureus, methicillin-resistant S. aureus (MRSA) and Bacillus cereus, with minimum inhibitory concentration (MIC) values ranging from 6.25 to 12.5 μg/mL. Compound 3 exhibited antibacterial activity against B. cereus with the MIC value of 12.5 μg/mL.Entities:
Keywords: Daldinia eschscholtzii; antibacterial activity; naphthoquinones; polyketides; α-glucosidase inhibitory activity
Mesh:
Substances:
Year: 2019 PMID: 31861107 PMCID: PMC6950716 DOI: 10.3390/md17120710
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 5.118
Figure 1Chemical structures of 1–10.
Figure 2Key 1H-1H COSY and HMBC correlations in 1–5.
1H and 13C NMR spectroscopic data (400 and 100 MHz) for 1 and 2 in CDCl3.
| Position | 1 | 2 | ||
|---|---|---|---|---|
| 1 | 126.0, C | 125.7, C | ||
| 2 | 135.3, CH | 6.64, d (8.0) | 134.0, CH | 6.90, d (8.4) |
| 3 | 105.4, CH | 6.07, d (8.0) | 107.6, CH | 6.22, d (8.4) |
| 4 | 156.2, C | 158.8, C | ||
| 5 | 208.1, C | 208.1, C | ||
| 6 | 46.8, CH2 | 3.12, t (7.2) | 46.9, CH2 | 3.10, dd (7.8, 6.6) |
| 7 | 17.9, CH2 | 1.75, m | 18.0, CH2 | 1.73, m |
| 8 | 14.1, CH3 | 1.01, t (7.4) | 14.0, CH3 | 0.99, t (7.4) |
| 9 | 161.0, C | 158.3, C | ||
| 10 | 111.7, C | 110.2, C | ||
| 1′ | 29.5, CH | 4.54, dd (5.2, 0.8) | 32.0, CH2 | 4.44, dd (10.4, 8.0) |
| 2′ | 34.5, CH2 | 1.89, ddd (14.0, 11.6, 5.2)2.07, dt (14.0, 2.0) | 39.1, CH2 | 1.77, ddd (14.0, 11.2, 10.4)2.39, ddd (14.0, 8.0, 1.6) |
| 3′ | 67.9, CH | 3.98, ddq (11.6, 6.4, 2.0) | 72.6, CH | 4.09, ddq (11.2, 6.4, 1.6) |
| 5′ | 109.7, CH | 6.55, brd (8.0) | 110.5, CH | 6.58, br d (8.0) |
| 6′ | 128.1, CH | 7.14, dd (8.0, 7.8) | 127.8, CH | 7.11, dd (8.0, 7.8) |
| 7′ | 102.2, CH | 6.42, d (7.8) | 103.8, CH | 6.42, br d (7.8) |
| 8′ | 158.1, C | 158.6, C | ||
| 9′ | 156.8, C | 158.0, C | ||
| 10′ | 109.5, C | 114.0, C | ||
| 3′-Me | 21.5, CH3 | 1.30, d (6.4) | 21.3, CH3 | 1.38, d (6.4) |
| 8′-OMe | 55.8, CH3 | 3.63, s | 55.7, CH3 | 3.48, s |
| 9-OH | 13.1, s | |||
Figure 3Comparison of experimental and calculated ECD spectra of 1 and 2 in MeOH at the B3LYP/6-311 + G (d, p) level.
1H and 13C NMR spectroscopic data (400 and 100 MHz) for 3–5 in CDCl3.
| Position | 3 | 4 | 5 | |||
|---|---|---|---|---|---|---|
| 1 | 179.8, C | 179.4, C | 157.5, C | |||
| 2 | 161.2, C | 161.3, C | 99.0, CH | 6.71, d (2.2) | ||
| 3 | 109.5, CH | 6.05, s | 109.5, CH | 6.08, s | 158.1, C | |
| 4 | 190.9, C | 191.0, C | 98.8, CH | 6.51, d (2.2) | ||
| 4a | 111.7, C | 113.9, C | 139.0, C | |||
| 5 | 159.7, C | 156.0, C | 114.5, CH | 7.30, s | ||
| 6 | 134.2, C | 134.7, C | 127.7, C | |||
| 7 | 145.1, C | 147.9, C | 140.5, C | |||
| 8 | 121.4, CH | 7.50, s | 112.6, CH | 7.56, s | 150.6, C | |
| 8a | 159.7, C | 131.8, C | 115.4, C | |||
| 9 | 11.9, CH3 | 2.25, s | 72.1, CH2 | 5.20, s | 73.3, CH2 | 5.16, s |
| 10 | 20.8, CH3 | 2.36, s | 74.3, CH2 | 5.16, s | 71.7, CH2 | 5.26, s |
| 1-OMe | 56.2, CH3 | 3.97, s | ||||
| 2-OMe | 56.7, CH3 | 3.90, s | 56.9, CH3 | 3.93, s | ||
| 3-OMe | 55.4, CH3 | 3.89, s | ||||
| 8-OMe | 61.6, CH3 | 3.84, s | ||||
| 5-OH | 12.61, s | 12.34, s | ||||
Antibacterial activity for 1–3.
| Compound | MIC (μg/mL) | ||
|---|---|---|---|
|
| MRSA |
| |
|
| 6.25 | 12.5 | 6.25 |
|
| 12.5 | 12.5 | 6.25 |
|
| >25 | >25 | 12.5 |
| Ciprofloxacin | 0.31 | 1.25 | 1.25 |
Ciprofloxacin was used as a positive control.